Physician profile
Steven Ward
NPI 1306289764
$1,717.53
in general payments reported to CMS, 2019-2025
12 companies · $469 in 2025
The $469 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2021: $100 · 2022: $427 · 2023: $89.60 · 2024: $145 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $562.44 | 2019-2025 | Mako, Alphavent |
| Medical Device Business Services, INC. | $305.05 | 2022 | |
| Smith+Nephew, INC. | $207.51 | 2019-2025 | Redapt, Evos, Evos Mini |
| Depuy Synthes Sales INC. | $170.80 | 2022-2024 | Attune, Na |
| Innovation Technologies INC | $139.38 | 2019-2025 | Irrisept |
| Amgen INC. | $121.83 | 2025 | Evenity |
| Ethicon US, LLC | $81.33 | 2019 | |
| Pacira Therapeutics, INC. | $46.16 | 2019 | |
| Djo, LLC | $37.57 | 2024 | Cmf |
| Bioventus LLC | $15.72 | 2025 | Durolane |
| Orthofix Medical, INC. | $15.39 | 2023 | Physio-Stim |
| Convatec INC. | $14.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.